Tower Research Capital LLC (TRC) - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 1 filers reported holding IMMUNITYBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$11,068
-71.3%
6,549
-52.8%
0.00%
-100.0%
Q2 2023$38,556
+78585.7%
13,869
-48.7%
0.00%
-50.0%
Q1 2023$49
+48.5%
27,042
+326.8%
0.00%
+100.0%
Q4 2022$33
-99.9%
6,336
-1.7%
0.00%0.0%
Q3 2022$32,000
+45.5%
6,448
+11.6%
0.00%
Q2 2022$22,000
-89.9%
5,778
-85.1%
0.00%
-100.0%
Q1 2022$218,000
+37.1%
38,855
+48.4%
0.00%
-33.3%
Q4 2021$159,000
+37.1%
26,182
+119.6%
0.00%0.0%
Q3 2021$116,000
+11.5%
11,920
+64.0%
0.00%0.0%
Q2 2021$104,000
+166.7%
7,269
+343.5%
0.00%
+200.0%
Q1 2021$39,0001,6390.00%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2023
NameSharesValueWeighting ↓
CVI Holdings, LLC 226,916$383,4880.76%
HARBOURVEST PARTNERS LLC 335,709$567,3480.19%
ALLEN HOLDING INC /NY 687,571$1,161,9950.16%
ARMISTICE CAPITAL, LLC 3,476,000$5,874,4400.09%
Clearwater Capital Advisors, LLC 394,599$666,8730.08%
SHEETS SMITH WEALTH MANAGEMENT 273,879$462,8560.07%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$162,9720.06%
WEALTH EFFECTS LLC 53,500$90,4150.04%
Virtus ETF Advisers LLC 34,461$58,2390.04%
FISHMAN JAY A LTD/MI 162,000$273,7800.04%
View complete list of IMMUNITYBIO INC shareholders